Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER2+ Metastatic Breast Cancer (MBC) × Patient Navigation × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 4 Breast Neoplasms 4 Lung Neoplasms 3 Uterine Cervical Neoplasms 2 Hematopoietic and Lymphatic System Neoplasm 2 Pyloric Stenosis, Hypertrophic 1 Overweight 1 Obesity 1 Neoplasms 1 HER2+ Metastatic Breast Cancer (MBC) 1 Diabetes Mellitus 1 Cardiovascular Diseases 1 Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Patient Navigation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06983691 2026-03-06

Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib

Duke University

Phase NA Not yet recruiting

HER2+ Metastatic Breast Cancer (MBC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡